# Treatment options for frontotemporal dementia
Frontotemporal dementia (FTD) currently has no cure. Treatment focuses on relieving symptoms, maintaining daily functioning for as long as possible, and improving quality of life. The approach is always personalized: what helps depends on which form of FTD someone has (behavioral changes, language loss, or motor problems), how advanced the disease is, and which symptoms are most prominent at that time.
Medications for behavioral and personality changes
The behavioral variant of FTD (bvFTD) is often accompanied by impulsivity, disinhibition, apathy, or inappropriate behavior. These manifestations can be distressing for the person themselves and for loved ones.
**Antidepressants (selective serotonin reuptake inhibitors, SSRIs)**
ProveniIncluded in official guidelines, or approved by EMA or FDA
SSRIs such as sertraline, citalopram, or fluoxetine are often used when apathy, depression, or obsessive thoughts predominate. They work by maintaining serotonin levels in the brain, which can help stabilize mood and reduce impulsive behaviors. Side effects can include headache, insomnia, nausea, or sexual side effects. In some people, fatigue occurs earlier. These medications do not work equally well for everyone, and it can take several weeks before effects become noticeable.
**Atypical antipsychotics**
ResearchediPositive results in clinical studies, not yet standard treatment
Medications such as risperidone or aripiprazole are sometimes suggested when behavioral changes are severe—aggression, highly impulsive behavior, or extreme restlessness. They work by reducing certain brain signals. However, in older people and people with dementia, there is a risk of side effects such as drowsiness, increased risk of falls and stroke, and metabolic changes. This is therefore something that must be carefully weighed.
**Lithium**
ResearchediPositive results in clinical studies, not yet standard treatment
Lithium is sometimes investigated for people in whom impulsivity and aggression are dominant. It can help dampen mood fluctuations. It requires regular blood tests because the dosage must closely match what the body can tolerate, and side effects can include tremors, thirst, or kidney function loss. This medication is rarely a first choice for FTD.
Medications for speech and language problems
Primary progressive aphasia (PPA), a form of FTD in which speech and language decline, does not respond directly to medications. There is no pill that brings language back. However, medical treatments can help control surrounding symptoms—such as depression from language loss, or feeding problems.
**Speech-language pathology and communication aids**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Speech-language pathologists help people with PPA adapt their communication as their speech declines. This can involve training in alternative communication methods (signing, pictures, digital devices, writing), training in clearer speech for as long as that is still possible, and advice for loved ones on how to communicate. Recent research in Germany shows that speech-language pathology care is widely used and valued by patients and families. This is not a medication, but it is an evidence-based treatment.
Medications for motor manifestations
Some forms of FTD are accompanied by ALS-like manifestations (muscle weakness, muscle cramps). If Parkinson-like symptoms occur, certain medications can be considered.
**Riluzole**
ProveniIncluded in official guidelines, or approved by EMA or FDA
This medication is approved for ALS and is sometimes also given to FTD patients with ALS overlap. It may slightly slow the progression of muscle weakness. Side effects include nausea, fatigue, and elevated liver values (which must be monitored).
**Levodopa and dopamine agonists**
ResearchediPositive results in clinical studies, not yet standard treatment
When Parkinson's symptoms (rigidity, slowness, tremor) come to the fore, these medications can sometimes help. They work by increasing dopamine levels in certain brain regions. Side effects include long-term movement disorders, hallucinations, and confused behavior, so they are used cautiously.
Treatment of nutritional problems and swallowing disorders
As FTD progresses, swallowing difficulties can occur. The person may have difficulty safely consuming food, which leads to malnutrition and aspiration risk.
**Speech-language pathology evaluation and adaptations**
ProveniIncluded in official guidelines, or approved by EMA or FDA
A speech-language pathologist can assess how swallowing function still works, which food forms are safe, and which techniques help. This may include thickened liquids, puréed food, adapted eating positions, or advice on eating speed. This prevents serious complications.
**Nutritional supplements**
ProveniIncluded in official guidelines, or approved by EMA or FDA
When normal food does not provide sufficient nutrients, nutritional drinks can help maintain energy and fluid balance. This is supportive; it does not stop the disease.
Experimental and research directions
**C9orf72-related therapies**
ExperimentaliOngoing in study setting, outcome still unknown
Part of inherited FTD is caused by mutations in the C9orf72 gene. Research shows that this gene is involved in cellular waste removal and inflammatory responses. Various experimental approaches are being investigated: gene suppression (weakening the harmful gene), anti-inflammatory agents, and cell therapies. These are still in research stages and not standard available.
ExperimentaliOngoing in study setting, outcome still unknown
Progranulin replacement therapies are being investigated for people with progranulin deficiency (a hereditary cause of FTD). The goal is to supplement the missing deficient protein to restore normal cell function. These are not yet available outside of research.
**Immunomodulation and anti-inflammatory treatment**
ResearchediPositive results in clinical studies, not yet standard treatment
Recent research suggests that inflammatory processes in the brain play a role. Agents that dampen the immune response or inhibit specific inflammatory pathways are being studied. This is still mainly laboratory work and early clinical testing.
Symptomatic support
**Antidepressants for secondary depression**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Many people with FTD become depressed due to awareness of the disease or brain damage itself. SSRIs (as mentioned earlier) can help.
**Sleep-promoting measures**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Sleep problems are common. Regular sleep schedules, avoiding stimulants, and sometimes careful use of melatonin or certain sedating antidepressants can help. Sleep medications should be used cautiously as they can worsen confusion.
**Pain management**
ProveniIncluded in official guidelines, or approved by EMA or FDA
If pain occurs (for example due to movement restrictions or comorbidities), paracetamol or mild analgesics can be used. NSAIDs (such as ibuprofen) require caution due to gastrointestinal and kidney risks.
Psychological and social support
**Psychotherapy and counseling**
ProveniIncluded in official guidelines, or approved by EMA or FDA
For the patient themselves, especially in early stages, and for caregivers, psychological support helps in coping with diagnosis and loss. This does not directly improve neurological symptoms, but contributes significantly to well-being.
**Occupational therapy and physical training**
ProveniIncluded in official guidelines, or approved by EMA or FDA
Occupational therapists help adapt daily activities so that someone can remain independent longer. Physical therapy supports mobility and prevention of contractures. Regular activity can also help counter apathy.
---
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._